ebook Munafa Stock Market Course + Intraday & FNO calls  

       

InnatePharma IPHA full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI

Innate Pharma IPHA WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NASDAQ stock exchange

Daily price and charts and targets InnatePharma

Strong intraday Stock price targets for InnatePharma are 2.12 and 2.24

Intraday Target 12.06
Intraday Target 22.12
Intraday Target 32.18
Intraday Target 42.24
Intraday Target 52.3

Daily price and volume Innate Pharma

Date Closing Open Range Volume
Fri 14 August 2026 2.18 (-14.17%) 2.18 2.12 - 2.24 0.1321 times
Thu 13 August 2026 2.54 (2.83%) 2.61 2.48 - 2.71 0.2482 times
Wed 12 August 2026 2.47 (14.88%) 2.50 2.44 - 2.64 0.4816 times
Tue 11 August 2026 2.15 (-3.15%) 2.32 2.15 - 2.34 0.5575 times
Mon 10 August 2026 2.22 (28.32%) 2.11 2.07 - 2.48 8.5061 times
Fri 07 August 2026 1.73 (-3.35%) 1.73 1.72 - 1.73 0.0062 times
Thu 06 August 2026 1.79 (1.13%) 1.78 1.60 - 1.79 0.0041 times
Wed 05 August 2026 1.77 (-1.12%) 1.71 1.71 - 1.80 0.0022 times
Tue 04 August 2026 1.79 (4.07%) 1.76 1.75 - 1.81 0.0029 times
Mon 03 August 2026 1.72 (-1.71%) 1.75 1.69 - 1.77 0.059 times
Fri 31 July 2026 1.75 (0%) 1.76 1.72 - 1.76 0.0115 times

 Daily chart InnatePharma

Weekly price and charts InnatePharma

Strong weekly Stock price targets for InnatePharma IPHA are 2.13 and 2.77

Weekly Target 11.68
Weekly Target 21.93
Weekly Target 32.32
Weekly Target 42.57
Weekly Target 52.96

Weekly price and volumes for Innate Pharma

Date Closing Open Range Volume
Fri 14 August 2026 2.18 (26.01%) 2.11 2.07 - 2.71 9.002 times
Fri 07 August 2026 1.73 (-1.14%) 1.75 1.60 - 1.81 0.0676 times
Fri 31 July 2026 1.75 (-1.69%) 1.84 1.68 - 1.91 0.0467 times
Fri 24 July 2026 1.78 (1.71%) 1.72 1.72 - 1.86 0.0158 times
Fri 17 July 2026 1.75 (-2.23%) 1.78 1.72 - 1.89 0.0399 times
Fri 10 July 2026 1.79 (-0.56%) 1.90 1.76 - 1.95 0.0374 times
Thu 02 July 2026 1.80 (0.56%) 1.80 1.77 - 1.92 0.0629 times
Fri 26 June 2026 1.79 (-1.1%) 1.89 1.76 - 1.96 0.0561 times
Thu 18 June 2026 1.81 (2.84%) 1.81 1.75 - 1.84 0.0856 times
Fri 12 June 2026 1.76 (2.92%) 1.73 1.73 - 1.86 0.5861 times
Fri 05 June 2026 1.71 (-6.56%) 1.81 1.71 - 1.89 0.1351 times

 weekly chart InnatePharma

Monthly price and charts InnatePharma

Strong monthly Stock price targets for InnatePharma IPHA are 1.89 and 3

Monthly Target 11.05
Monthly Target 21.62
Monthly Target 32.1633333333333
Monthly Target 42.73
Monthly Target 53.27

Monthly price and volumes Innate Pharma

Date Closing Open Range Volume
Fri 14 August 2026 2.18 (24.57%) 1.75 1.60 - 2.71 3.1465 times
Fri 31 July 2026 1.75 (-4.89%) 1.86 1.68 - 1.95 0.054 times
Tue 30 June 2026 1.84 (0.55%) 1.81 1.71 - 1.96 0.3157 times
Fri 29 May 2026 1.83 (27.08%) 1.49 1.32 - 2.62 1.1302 times
Thu 30 April 2026 1.44 (12.5%) 1.33 1.32 - 1.75 0.2466 times
Tue 31 March 2026 1.28 (-25.58%) 1.62 1.17 - 1.71 0.1692 times
Fri 27 February 2026 1.72 (-6.01%) 1.87 1.57 - 1.87 0.1373 times
Fri 30 January 2026 1.83 (4.57%) 1.82 1.70 - 1.89 0.1596 times
Wed 31 December 2025 1.75 (-10.26%) 1.93 1.63 - 2.01 0.2348 times
Fri 28 November 2025 1.95 (-1.02%) 1.88 1.73 - 2.43 4.4063 times
Fri 31 October 2025 1.97 (2.07%) 1.97 1.95 - 2.40 0.2052 times

 monthly chart InnatePharma

Yearly price and charts InnatePharma

Strong yearly Stock price targets for InnatePharma IPHA are 1.68 and 3.22

Yearly Target 10.48
Yearly Target 21.33
Yearly Target 32.02
Yearly Target 42.87
Yearly Target 53.56

Yearly price and volumes Innate Pharma

Date Closing Open Range Volume
Fri 14 August 2026 2.18 (24.57%) 1.82 1.17 - 2.71 0.4327 times
Wed 31 December 2025 1.75 (-4.89%) 1.94 1.60 - 2.63 0.9231 times
Tue 31 December 2024 1.84 (-34.29%) 2.78 1.29 - 3.51 0.9979 times
Fri 29 December 2023 2.80 (-24.93%) 3.42 1.81 - 3.97 0.1289 times
Fri 30 December 2022 3.73 (-18.2%) 4.80 1.90 - 4.87 0.2905 times
Fri 31 December 2021 4.56 (11.49%) 4.23 3.02 - 11.95 4.9876 times
Thu 31 December 2020 4.09 (-36.49%) 8.24 3.30 - 8.24 0.1535 times
Tue 31 December 2019 6.44 (0%) 5.61 5.61 - 6.75 0.0859 times
Sun 16 August 2026 (0%) - 0 times

Indicator Analysis of InnatePharma

Tomorrow's movement Prediction of Innate Pharma IPHA appears to be in uptrend. But this trend seems to be weakening.

Price is above an important level of 2.08 on charts, and as long as price remains above this level, the uptrend of stock might continue.

Tomorrow's movement Prediction of Innate Pharma IPHA made a major fall in previous days. This happens when sentiment changes towards negative. This fall might deepen in coming days.

Tomorrow's movement Prediction of Innate Pharma IPHA appears undecisive. It can be Bearish or Bullish. You should wait for the first half to take a decision on this stock. If it shows signs of weakness in the latter half, then this trend can continue tomorrow as well. Similarly, if it shows signs of strength in the latter half, then this trend can continue in the next trading session as well.

Tomorrow's movement Prediction of Innate Pharma IPHA is bullish. The stock is trading above weekly resistance and downside can only be expected once it trades below 1.77

Munafa value: 69 as on Fri 14 August 2026

This Munafa value indicates that the stock is moving sideways and there is no definite momentum in the stock.

SMA20 is at 2 and price is deviating by 1 points

Upper Bollinger band is at 3 and lower is at 2, while middle bands are at 2 and 3

Price is coming down

Price is above 20day SMA

Price is in upper range of bands

Price action analysis of InnatePharma (IPHA) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

ADX buy sell signal for InnatePharma stock for short term is BUY. Signal strength is Weak and stock is losing momentum.

MACD generated a BUY signal for InnatePharma in short term and the buy signal is strong.

InnatePharma Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.

Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down

CCI has generated a SELL signal for InnatePharma in short term but SELL signal is weak.

RSI is generating a BUY signal in short term but buying is losing momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of InnatePharma is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 2.23 and InnatePharma IPHA stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the InnatePharma IPHA stock. Volume based technical analysis of InnatePharma IPHA stock is negative.

InnatePharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

DMA SMA EMA moving averages of Innate Pharma IPHA

DMA (daily moving average) of Innate Pharma IPHA

DMA period DMA value
5 day DMA 2.31
12 day DMA 1.99
20 day DMA 1.9
35 day DMA 1.86
50 day DMA 1.84
100 day DMA 1.7
150 day DMA 1.69
200 day DMA 1.74

EMA (exponential moving average) of Innate Pharma IPHA

EMA period EMA current EMA prev EMA prev2
5 day EMA2.252.282.15
12 day EMA2.082.061.97
20 day EMA1.981.961.9
35 day EMA1.931.911.87
50 day EMA1.891.881.85

SMA (simple moving average) of Innate Pharma IPHA

SMA period SMA current SMA prev SMA prev2
5 day SMA2.312.222.07
12 day SMA1.991.961.89
20 day SMA1.91.881.84
35 day SMA1.861.851.83
50 day SMA1.841.831.82
100 day SMA1.71.691.68
150 day SMA1.691.691.68
200 day SMA1.741.741.74

Videos related to: InnatePharma IPHA full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI

Hindi Video What Is Needed To Succeed In Stock Markets

InnatePharma IPHA full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI

 

Back to top